- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06365138
Analysis of Individual Activity at the Time of Aortic Rupture in Patients With Abdominal Aortic Aneurysms
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The scientifically proven risk factors that significantly favor the rupture of an aortic aneurysm are female gender, the maximum diameter of the aortic aneurysm and the patient's current smoking status.
However, no analysis of the occupation performed at the time of aortic rupture of an abdominal aortic aneurysm has yet been carried out.
High arterial systolic blood pressure can promote aortic rupture. Blood pressure peaks can occur during physical exertion, for example when lifting heavy loads or during defecation.
Patients with an existing intact aortic aneurysm are currently advised to avoid such behaviors as a preventive measure. This includes, among other things, the practice of strength training or certain types of sport. This can subsequently lead to a reduction in quality of life, although this cannot currently be substantiated by scientific data. There is also no current guideline recommendation in this regard.
Furthermore, the role of stress and / or emotionally stressful events in connection with the occurrence of aortic ruptures has not yet been recorded in the literature. There is work on this in connection with aortic dissections, which postulates that an increase in emotional or psychological stress can lead to acute hypertension, which can cause a previously damaged aorta to rupture. A similar pathomechanism would also be conceivable for the rupture of aortic aneurysms.
There are indications that, in addition to gender-specific differences in the occurrence of aortic ruptures, there is also a different risk of rupture based on certain pre-existing conditions, dietary habits and age.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Tobias Warm, MD
- Phone Number: +49821400161068
- Email: tobias.warm@uk-augsburg.de
Study Contact Backup
- Name: Yvonne Gosslau, MD
- Phone Number: +49821400161977
- Email: yvonne.gosslau@uk-augsburg.de
Study Locations
-
-
-
Augsburg, Germany, 86156
- Recruiting
- University Hospital Augsburg
-
Contact:
- Tobias Warm, MD
- Phone Number: +49821400161068
- Email: tobias.warm@uk-augsburg.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
All patients with ruptured aortic aneurysm in Augsburg University Hospital form 01/01/24 till 12/31/29 for the prospecitve part of the trial.
All patients who have been treated for a ruptured aortic aneurysm in Augsburg University Hospital form 01/01/13 till 12/31/23 for the retrospectitve part of the trial.
Description
Inclusion Criteria:
- inclusion of all patients with ruptured aortic aneurysm in Augsburg University Hospital
- Written consent to participate in the study by the patient or their legal representative
Exclusion Criteria:
- Lack of consent
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Occupation at the time of the aortic aneurysm rupture
Time Frame: Occupation at the day of the aortic rupture and the three days prior
|
Occupation at the time of the aortic aneurysm rupture
|
Occupation at the day of the aortic rupture and the three days prior
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Alexander Hyhlik-Duerr, Prof., University Hospital Augsburg Vascular Surgery
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Aortic Rupture
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.